Home / Indicators / Medicine spending vs Sales growth at constant exchange rates Medicine spending vs Sales growth at constant exchange rates Medicine spending and Sales growth at constant exchange rates worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time Global, spaced by time
. Different units, drawn on separate scales and clipped to the years both
series publish — earlier history stays on each indicator's own page.
Read the values, not the heights.
Medicine spending
Unit: trillion USD · 2 observations
Line chart
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
0.5
1
1.5
2
2.5
3
2023
2024
2025
2026
2027
2028
2029
2030
FORECAST
1.6
2.6
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
1
2
3
2023
2024
2025
2026
2027
2028
2029
2030
FORECAST
1.6
2.6
Medicine spending Medicine spending. 2 observations from 2023 to 2030, ranging from 1.6 trillion USD to 2.6 trillion USD, of which 1 are forecasts. Latest value 2.6 trillion USD (2030).
trillion USD
0
1
2
3
2023
2024
2025
2026
2027
2028
2029
2030
FORECAST
1.6
2.6
View the underlying data Sales growth at constant exchange rates
Unit: % · 2 observations
Line chart Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
2023
2024
2025
2026
2027
2028
2029
2030
3%
18%
Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
2023
2024
2025
2026
2027
2028
2029
2030
3%
18%
Sales growth at constant exchange rates Sales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026).
%
0
5
10
15
20
2023
2024
2025
2026
2027
2028
2029
2030
3%
18%
View the underlying data Provenance
Where these numbers come from Amount spent purchasing medicines from manufacturers before off-invoice discounts and rebates.
2 observations in Global · source
organisations: IQVIA
Percentage change in sales calculated at constant exchange rates over the specified period.
2 observations in Global · source
organisations: Roche, Sanofi
Data published under CC BY 4.0 .
Series A as JSON · Series B as JSON